feed,title,long_url,short_url
BioRxiv,Extracellular disintegration of viral proteins as an innovative strategy for developing broad-spectrum antivirals against coronavirus,https://biorxiv.org/cgi/content/short/2022.11.24.517008v1?rss=1,https://bit.ly/3ilAHdJ
BioRxiv,SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects,https://biorxiv.org/cgi/content/short/2022.11.24.517882v1?rss=1,https://bit.ly/3VwdaVE
BioRxiv,Highly potent antisense oligonucleotides (ASOs) targeting the SARS-CoV-2 RNA genome,https://biorxiv.org/cgi/content/short/2022.11.28.518195v1?rss=1,https://bit.ly/3GSMTN6
BioRxiv,Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants,https://biorxiv.org/cgi/content/short/2022.11.23.517532v1?rss=1,https://bit.ly/3XCzTBl
BioRxiv,Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ1.1 and XBB,https://biorxiv.org/cgi/content/short/2022.11.25.517977v1?rss=1,https://bit.ly/3GSMTwA
BioRxiv,Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein,https://biorxiv.org/cgi/content/short/2022.11.25.517953v1?rss=1,https://bit.ly/3GSMUk8
BioRxiv,Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2022.11.24.515932v1?rss=1,https://bit.ly/3XFOrjr
